CVR number 27576524
Industry 869900

FLAC MEDICAL ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.9% 9.5% 7.9% 7.5% 9.2%  
Credit score (0-100)  20 24 30 31 27  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  4.0 820 798 638 569  
EBITDA  4.0 495 465 310 197  
EBIT  4.0 495 465 310 197  
Pre-tax profit (PTP)  4.0 495.5 465.5 315.3 199.9  
Net earnings  2.6 381.7 361.5 244.6 154.9  
Pre-tax profit without non-rec. items  4.0 495 465 315 200  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  180 562 523 418 323  
Interest-bearing liabilities  0.0 0.0 58.0 55.4 132  
Balance sheet total (assets)  493 979 866 752 594  
Net Debt  -113 -317 -162 -205 53.8  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4.0 820 798 638 569  
Gross profit growth  -69.6% 20,407.5% -2.6% -20.1% -10.8%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  493 979 866 752 594  
Balance sheet change%  28.1% 98.5% -11.6% -13.2% -21.0%  
Added value  4.0 495.5 465.1 309.6 196.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 60.4% 58.3% 48.5% 34.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.9% 67.6% 50.7% 39.0% 29.7%  
ROI %  2.2% 134.1% 81.8% 59.9% 43.1%  
ROE %  1.4% 102.9% 66.6% 52.0% 41.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  36.5% 57.4% 60.4% 55.6% 54.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2,817.3% -63.9% -34.7% -66.2% 27.4%  
Gearing %  0.0% 0.0% 11.1% 13.2% 40.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.8% 0.7% 0.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 1.9 2.1 1.9 1.6  
Current Ratio  1.6 2.3 2.5 2.3 2.2  
Cash and cash equivalent  112.6 316.5 219.5 260.2 78.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  180.0 561.7 523.3 417.9 322.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 495 465 310 197  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 495 465 310 197  
EBIT / employee  0 495 465 310 197  
Net earnings / employee  0 382 362 245 155